The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator
- PMID: 14673209
- DOI: 10.1159/000074624
The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator
Abstract
Cyclin-dependent kinase 5 (Cdk5) displays kinase activity predominantly in post-mitotic neurons and its physiological roles are unrelated to cell cycle progression. Cdk5 is activated by its binding to a neuron-specific activator, p35 or p39. The protein amount of p35 or p39 is a primary determinant of the Cdk5 activity in neurons, with the amount of p35 or p39 being determined by its synthesis and degradation. The expression of p35 is induced in differentiated neurons and is enhanced by extracellular stimuli such as neurotrophic factors or extracellular matrix molecules, specifically those acting on the ERK/Erg pathway. p35 is a short-lived protein and its degradation determines the life span. Degradation is mediated by the ubiquitin/proteasome system, similar to that for cyclins in proliferating cells. Autophosphorylation of p35 by Cdk5 is a signal for ubiquitination/degradation, and the degradation of p35 is triggered by glutamate treatment in cultured neurons. p35 is cleaved to p25 by calpain at the time of neuronal cell death, and this limited cleavage is suggested to be the cause of neurodegenerative diseases such as Alzheimer's disease. Active Cdk5 changes the cellular localization by cleavage of p35 to p25; p35/Cdk5 is associated with membrane or cytoskeletons, but p25/Cdk5 is a soluble protein. Cleavage also increases the life span of p25 and changes the activity or substrate specificity of Cdk5. p25/Cdk5 shows higher phosphorylating activity to tau than p35/Cdk5 in a phosphorylation site-specific manner. Phosphorylation of p35 suppresses cleavage by calpain. Thus, phosphorylation of p35 modulates its proteolytic pattern, stimulates proteasomal degradation and suppresses calpain cleavage. Phosphorylation is age dependent, as p35 is phosphorylated in foetal brains, but unphosphorylated in adult brains. Therefore, foetal phosphorylated p35 is turned over rapidly, whereas adult unphosphorylated p35 has a long life and is easily cleaved to p25 when calpain is activated. p39 is also a short-lived protein and cleaved to the N-terminal truncation form of p29 by calpain. How the metabolism of p39 is regulated, however, is a future problem to be investigated.
Copyright 2003 S. Karger AG, Basel
Similar articles
-
Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation.J Neurosci. 2003 Feb 15;23(4):1189-97. doi: 10.1523/JNEUROSCI.23-04-01189.2003. J Neurosci. 2003. PMID: 12598607 Free PMC article.
-
Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39.Biochemistry. 2010 Jul 6;49(26):5482-93. doi: 10.1021/bi100631f. Biochemistry. 2010. PMID: 20518484
-
Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.Brain Res Mol Brain Res. 2002 Oct 15;106(1-2):50-6. doi: 10.1016/s0169-328x(02)00409-6. Brain Res Mol Brain Res. 2002. PMID: 12393264
-
Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide.Biochim Biophys Acta. 2004 Mar 11;1697(1-2):143-53. doi: 10.1016/j.bbapap.2003.11.020. Biochim Biophys Acta. 2004. PMID: 15023357 Review.
-
The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.Eur J Biochem. 2001 Mar;268(6):1518-27. doi: 10.1046/j.1432-1033.2001.02024.x. Eur J Biochem. 2001. PMID: 11248668 Review.
Cited by
-
Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid.Proc Natl Acad Sci U S A. 2015 May 26;112(21):6742-7. doi: 10.1073/pnas.1422001112. Epub 2015 May 11. Proc Natl Acad Sci U S A. 2015. PMID: 25964330 Free PMC article.
-
PHF-like tau phosphorylation in mammalian hibernation is not associated with p25-formation.J Neural Transm (Vienna). 2009 Mar;116(3):345-50. doi: 10.1007/s00702-008-0181-x. Epub 2009 Jan 28. J Neural Transm (Vienna). 2009. PMID: 19184336
-
The Role of CDK5 in Tumours and Tumour Microenvironments.Cancers (Basel). 2020 Dec 31;13(1):101. doi: 10.3390/cancers13010101. Cancers (Basel). 2020. PMID: 33396266 Free PMC article. Review.
-
Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.J Neurosci. 2008 Mar 5;28(10):2624-32. doi: 10.1523/JNEUROSCI.5245-07.2008. J Neurosci. 2008. PMID: 18322105 Free PMC article.
-
Suppression of mutant Huntingtin aggregate formation by Cdk5/p35 through the effect on microtubule stability.J Neurosci. 2008 Aug 27;28(35):8747-55. doi: 10.1523/JNEUROSCI.0973-08.2008. J Neurosci. 2008. PMID: 18753376 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous